1st Quarter - Amendment

ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report May 4, 2020 — Replaced
1st Quarter - Amendment Jul 20, 2020 — Replaced
1st Quarter - Amendment (this page) Feb 12, 2021 — Replaced
1st Quarter - Amendment Apr 22, 2021 — Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-Signed letter in support of the reauthorization of the Older Americans Act of 2020 (H.R. 4334) -Signed letter supporting H.R. 3423 and S. 3125 in support of the Alzheimer's Research and Caregiving Trust Fund -Signed letter urging Congress to fund evidenced-based falls prevention programs for the Administration for Community Living and the Centers for Disease Control and Prevention. -Signed a letter urging the Administration to not restrict the supply chain of medical devices of pharmaceuticals abroad during the COVID-19 pandemic -Signed a letter to Congress asking for investment in vision and eye health funding surveillance, research, and evidence-based public health interventions. -Signed letter encouraging CMS to incentive care coordination for people who experienced an osteoporotic fracture and a risk for another. The letter also called for the CDC to develop a national education campaign to reduce the rate of bone fractures and falls.

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern Rep. Ed Perlmutter

Contacted: SENATE; President of the U.S.; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3423 (116th), H.R. 4334 (116th), S. 3125 (116th)

Medicare/Medicaid MMM

-Signed letter to the Centers for Medicare and Medicaid over the concern in the increase in out-of-pocket expenses in Medicare Part D in 2020. -Signed letter to the Senate in support of S.2911, the Seniors Prescription Drug Relief Act of 2019.

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern Rep. Ed Perlmutter

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES; President of the U.S.

Bills named: S. 2911 (116th)

Budget/Appropriations BUD

-Signed letter recommending $4.5 billion in additional annual funding for CDC, state, local, tribal and territorial core public health infrastructure to pay for such essential activities as disease surveillance, epidemiology, laboratory capacity, all-hazards preparedness and response; policy development and support; communications; community partnership development; and organizational competencies. -Participated in a virtual hill day for the Alliance for a Stronger FDA. The organizations requested an additional $120 million in budget authority for FY2021. -Signed a letter to Congress urging $471 million in budget authority for the Agency for Healthcare Research and Quality

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern, Rep. Ed Perlmutter

Contacted: President of the U.S.; White House Office; SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

-Signed letter in support of the use of fetal tissue for biomedical research -Signed letter in support of H.R. 5668, the Making Objective Drug Evidence Revisions for New Labeling Act (MODERN Labeling Act).

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern. Rep. Ed Perlmutter

Contacted: White House Office; SENATE; President of the U.S.; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5668 (116th)

Taxation/Internal Revenue Code TAX

-Signed letter asking Congress to consider the needs of nonprofit organizations in financial stimulus packages to address the economic downturn caused by the 2020 COVID-19 pandemic.

LobbyistCovered position, as disclosed
RYNE C. CARNEY —

Contacted: President of the U.S.; White House Office; HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.